Blane Chong, MD
Sports Medicine · Honolulu, HINPI 1669584967
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,316 of the $1,842 with a category attached, or 71.4%. Pacira Pharmaceuticals Incorporated accounts for 79.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,458 and has fallen 97.6% since, to $35 in 2025.
Across 31 payments — averaging $59.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Amgen$141
- Novo Nordisk$62
- Amarin Pharma, Inc.$60
- Elevate Surgical Co$35
- Bioventus LLC$28
- plus $44 from 3 others
What the payments were for
- Travel & lodging$1,31671%
- Food & beverage$52629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 6 | $1,472 |
| Amgen(2 entities) | 16 | $141 |
| Novo Nordisk | 3 | $62 |
| Amarin Pharma, Inc. | 1 | $60 |
| Elevate Surgical Co | 1 | $35 |
| Bioventus LLC | 1 | $28 |
| Impactortho, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$1,418
How this compares
$1,842 in reported general payments places this provider in the 60th percentile of 31 sports medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 98 | $2,818 |
| Losartan Potassium | 109 | $2,394 |
| Omeprazole | 39 | $1,362 |
| Amlodipine Besylate | 51 | $920 |
| Simvastatin | 50 | $871 |
| Tamsulosin Hcl | 28 | $761 |
| Fluticasone Propionate | 23 | $758 |
| Felodipine ErFelodipine | 12 | $742 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 19 | $716 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 12 | $648 |
| Metoprolol Succinate | 23 | $647 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $622 |
| Metformin Hcl | 46 | $581 |
| Lisinopril | 50 | $509 |
| Allopurinol | 33 | $344 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Honolulu
- Jeffery HarpstriteHonolulu$153K
- Alexander GarberHonolulu$43K
- Daniel LimHonolulu$28K
- Megan KubaHonolulu$9K
- Jae YouHonolulu$8K
- Jay MarumotoHonolulu$3K
- Darryl KanHonolulu$2K
- Brandon TeruyaHonolulu$2K
- Garret NoguchiHonolulu$1K
- Elizabeth IgnacioHonolulu$574
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.